NEPOR

Trademark usage description

diagnostic kits comprised of medical diagnostic reagents, in particular reagents for testing, determining and/or analyzing the level of protein and/or Read More

Classification Information

Class [005]
Diagnostic kits comprised of medical diagnostic reagents, in particular reagents for testing, determining and/or analyzing the level of protein and/or RNA expression in a biological sample derived from an individual, in particular the level of EPH-B4 and/or Ephrin A1 receptor expression in a sample derived from tumor tissue or bodily fluids; diagnostic assays for testing of cells, tissue or bodily fluids for use in patient stratification and disease detection, namely cancer; biological and medical preparations and articles, in particular reagents for use in diagnostic and clinical tests, diagnostic biomarker reagents for medical purposes, in particular for enabling treatment decisions in connection with cancer patients, in particular with the administration of erythropoietin; pharmaceuticals for the treatment of cancer; cancer therapeutics, in particular for use in precision medicine; none of the aforesaid goods being for veterinary purposes and none being for dealing with insects, or vermin

Classification kind code

Class [044]
Medical testing for diagnostic or treatment purposes; molecular testing for medical purposes; consulting services in the field of diagnostic medical testing and precision medicine, in particular in relation with treatment decisions and the administration of cancer drugs; health care consulting in the field of cancer treatment; providing online information, via the internet and mobile applications, in the fields of genetic and molecular testing and cancer diagnosis and treatment; medical and pharmaceutical consulting services relating to patient specific medical treatment options, in particular cancer treatment options; medical consulting services relating to the treatment and diagnosis of individuals; providing pharmaceutical and medical information, in particular information about drug safety and drug compatibility in relation to cancer therapy and the treatment of individuals, in particular in connection with the administration of erythropoietin; medical consulting services in the fields of patient treatment and treatment protocols, diagnostic molecular testing, drug safety, dosage assessment, in particular in the field of cancer treatment therapy for others; none of the aforesaid services being for veterinary purposes and none being for dealing with insects, or vermin

Classification kind code

Mark Details

Serial Number

1731445

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 51 on 17^th Mar 2017	Allowance Notice Sent
Submitted for opposition 42 on 30^th Nov 2016	Advertised
Submitted for opposition 26 on 17^th Nov 2016	Approved
Submitted for opposition 27 on 27^th Sept 2016	Approval Notice Sent
Submitted for opposition 15 on 5^th Jul 2016	Correspondence Created
Submitted for opposition 22 on 17^th Dec 2015	Search Recorded
Submitted for opposition 20 on 17^th Dec 2015	Examiner's First Report
Submitted for opposition 1 on 12^th Jun 2015	Created
Submitted for opposition 31 on 12^th Jun 2015	Formalized
Submitted for opposition 30 on 4^th Jun 2015	Filed